Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05721222 |
| Recruiting Status | Terminated |
| Condition | Non-Hodgkin Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | November 13, 2025 (Nov 13, 2025) |
As of March 2, 2026: Clinical trial NCT05721222 is currently terminated participants. This clinical trial study for non-hodgkin lymphoma is not currently accepting new participants at 14 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05721222 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05721222 was last updated Nov 13, 2025 (November 13, 2025). HelloStudys verifies this status automatically.